NO145083C - Fremgangsmaate for fremstilling av en vaksine for forhindring av graviditet. - Google Patents
Fremgangsmaate for fremstilling av en vaksine for forhindring av graviditet.Info
- Publication number
- NO145083C NO145083C NO751680A NO751680A NO145083C NO 145083 C NO145083 C NO 145083C NO 751680 A NO751680 A NO 751680A NO 751680 A NO751680 A NO 751680A NO 145083 C NO145083 C NO 145083C
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- pregnancy
- procedure
- preparation
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 2
- 230000035935 pregnancy Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/814—Pregnancy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
- Y10S436/818—Human chorionic gonadotropin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54467775A | 1975-01-28 | 1975-01-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO751680L NO751680L (nl) | 1976-07-29 |
NO145083B NO145083B (no) | 1981-10-05 |
NO145083C true NO145083C (no) | 1982-01-27 |
Family
ID=24173127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO751680A NO145083C (no) | 1975-01-28 | 1975-05-12 | Fremgangsmaate for fremstilling av en vaksine for forhindring av graviditet. |
Country Status (11)
Country | Link |
---|---|
US (1) | US4161519A (nl) |
AR (1) | AR217615A1 (nl) |
CA (1) | CA1054937A (nl) |
CH (1) | CH614626A5 (nl) |
DE (1) | DE2518546A1 (nl) |
DK (1) | DK145283C (nl) |
FI (1) | FI54997C (nl) |
IL (1) | IL47177A (nl) |
NL (1) | NL7505412A (nl) |
NO (1) | NO145083C (nl) |
SE (2) | SE432526B (nl) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4302386A (en) * | 1978-08-25 | 1981-11-24 | The Ohio State University | Antigenic modification of polypeptides |
US4384995A (en) * | 1980-01-16 | 1983-05-24 | The Ohio State University | Antigenic modification of polypeptides |
US6096318A (en) * | 1973-05-07 | 2000-08-01 | The Ohio State University | Antigenically modified HCG polypeptides |
US5698201A (en) * | 1973-05-07 | 1997-12-16 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
US6146633A (en) * | 1973-05-07 | 2000-11-14 | The Ohio State University | Method for treatment of antigenically modified polypeptides |
US5006334A (en) * | 1973-05-07 | 1991-04-09 | The Ohio State University | Antigenic modification of polypeptides |
US4691006A (en) * | 1983-03-04 | 1987-09-01 | Ohio State University | Antigenic modification of polypeptides |
US6143305A (en) * | 1973-05-07 | 2000-11-07 | The Ohio State University | Antigenically modified polypeptides composition |
US4767842A (en) * | 1973-05-07 | 1988-08-30 | The Ohio State University | Antigenic modification of polypeptides |
US4762913A (en) * | 1973-05-07 | 1988-08-09 | The Ohio State University | Antigenic modification of polypeptides |
US4526716A (en) * | 1981-11-20 | 1985-07-02 | The Ohio State University | Antigenic modification of polypeptides |
US4313871A (en) * | 1978-02-06 | 1982-02-02 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
US4397844A (en) * | 1978-02-24 | 1983-08-09 | Ciba-Geigy Corporation | Antigen derivatives and processes for their preparation |
US4268435A (en) * | 1979-02-06 | 1981-05-19 | Research Corporation | Chorionic gonadotropin derived antigen for early pregnancy test and contraceptive vaccine |
US4310455A (en) * | 1979-04-17 | 1982-01-12 | Research Corporation | Antigen for early pregnancy test and contraceptive vaccine |
US4376765A (en) * | 1980-03-31 | 1983-03-15 | Institut International De Pathologie Cellulaire Et Moleculaire | Medicaments, their preparation and compositions containing same |
US4749570A (en) * | 1981-12-31 | 1988-06-07 | The Governors Of The University Of Alberta | Targeting conjugates of albumin and therapeutic agents |
US4966888A (en) * | 1985-07-08 | 1990-10-30 | Cornell Research Foundation, Inc. | hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, antibodies thereto and contraceptive vaccine |
US4556555A (en) * | 1985-01-25 | 1985-12-03 | North Carolina State University | Process for the immunological neutering of animals |
US4722889A (en) * | 1985-04-02 | 1988-02-02 | Leeco Diagnostics, Inc. | Immunoassays using multiple monoclonal antibodies and scavenger antibodies |
CA1239346A (en) * | 1985-06-04 | 1988-07-19 | Gursaran P. Talwar | Birth control vaccine |
US4713366A (en) * | 1985-12-04 | 1987-12-15 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US5817753A (en) | 1985-12-04 | 1998-10-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US4855285A (en) * | 1985-12-04 | 1989-08-08 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US5762931A (en) * | 1992-12-31 | 1998-06-09 | National Institute Of Immunology | Anti-cancer utility of HCG vaccines |
WO1996015807A1 (en) * | 1994-11-21 | 1996-05-30 | Scofield Virginia L | Sperm as vaccine vectors |
US5997871A (en) * | 1996-06-24 | 1999-12-07 | University Of Maryland Biotechnology Insitute | Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
US6319504B1 (en) | 1996-06-24 | 2001-11-20 | University Of Maryland Biotechnology Institute | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
US6583109B1 (en) | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
US7994278B1 (en) | 1999-08-06 | 2011-08-09 | Nobel Biosciences Llc | Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) |
US6716428B1 (en) | 1999-10-06 | 2004-04-06 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US20030185845A1 (en) * | 2001-11-16 | 2003-10-02 | Steen Klysner | Novel immunogenic mimetics of multimer proteins |
HUP0402155A2 (hu) * | 2001-11-16 | 2005-01-28 | Pharmexa A/S | Multimer fehérjék új immunogén mimetikumai széleskörű T-sejt-epitóp-inszertekkel |
US20040018973A1 (en) * | 2002-01-25 | 2004-01-29 | University Of Pittsburgh | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
MXPA05005051A (es) | 2002-11-12 | 2006-03-10 | Albert B Deisseroth | Vacuna de vector adenoviral. |
EA008254B1 (ru) | 2003-05-09 | 2007-04-27 | Фармекса А/С | Детоксифицированный tnf и способ получения |
EP1687334B1 (en) | 2003-11-24 | 2014-01-08 | MicroVAX, LLC | Mucin antigen vaccine |
US8828957B2 (en) * | 2003-12-11 | 2014-09-09 | Microvax, Llc | Methods for generating immunity to antigen |
WO2006130525A2 (en) * | 2005-05-31 | 2006-12-07 | Sidney Kimmel Cancer Center | Methods for immunotherapy of cancer |
AU2006311752A1 (en) * | 2005-11-07 | 2007-05-18 | Sidney Kimmel Cancer Center | CD40 ligand fusion protein vaccine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH622426A5 (en) * | 1973-05-07 | 1981-04-15 | Univ Ohio | Contraceptive composition |
-
1975
- 1975-04-21 CA CA225,101A patent/CA1054937A/en not_active Expired
- 1975-04-25 DE DE19752518546 patent/DE2518546A1/de not_active Withdrawn
- 1975-04-25 IL IL47177A patent/IL47177A/xx unknown
- 1975-05-07 NL NL7505412A patent/NL7505412A/nl not_active Application Discontinuation
- 1975-05-07 AR AR258670A patent/AR217615A1/es active
- 1975-05-12 NO NO751680A patent/NO145083C/no unknown
- 1975-05-12 SE SE7505411A patent/SE432526B/xx not_active IP Right Cessation
- 1975-05-12 DK DK206975A patent/DK145283C/da active
- 1975-05-30 CH CH702175A patent/CH614626A5/xx not_active IP Right Cessation
- 1975-06-12 FI FI751746A patent/FI54997C/fi not_active IP Right Cessation
-
1977
- 1977-04-21 US US05/789,455 patent/US4161519A/en not_active Expired - Lifetime
-
1978
- 1978-07-05 SE SE7807571A patent/SE432706B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE432526B (sv) | 1984-04-09 |
NO145083B (no) | 1981-10-05 |
DE2518546A1 (de) | 1976-07-29 |
DK206975A (da) | 1976-07-29 |
FI54997B (fi) | 1979-01-31 |
SE7807571L (sv) | 1978-07-05 |
FI54997C (fi) | 1979-05-10 |
NL7505412A (nl) | 1976-07-30 |
IL47177A0 (en) | 1975-06-25 |
SE7505411L (sv) | 1976-07-29 |
US4161519A (en) | 1979-07-17 |
AR217615A1 (es) | 1980-04-15 |
CH614626A5 (nl) | 1979-12-14 |
SE432706B (sv) | 1984-04-16 |
NO751680L (nl) | 1976-07-29 |
DK145283B (da) | 1982-10-25 |
IL47177A (en) | 1979-01-31 |
CA1054937A (en) | 1979-05-22 |
DK145283C (da) | 1983-05-16 |
FI751746A (nl) | 1976-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO145083C (no) | Fremgangsmaate for fremstilling av en vaksine for forhindring av graviditet. | |
SE7505040L (sv) | Forfarande for framstellning av n-fosfonometylglycin. | |
SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
NO770366L (no) | Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder. | |
ES451642A1 (es) | Procedimiento de preparacion de arinas. | |
SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
NO151365C (no) | Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater. | |
SE436026B (sv) | Forfarande for framstellning av 13,14-dehydroprostaglandiner | |
SE409864B (sv) | Forfarande for framstellning av 4-imino-1,3-diazabicyklo(3.1.0)hexan-2-on | |
SE428015B (sv) | Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat | |
SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
SE7608177L (sv) | Forfarande for framstellning av a,beta-eteniska aldehyder | |
SE7601605L (sv) | Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol | |
SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
SE426067B (sv) | Forfarande for framstellning av 9-hydroxi-7,8,9,10-tetrahydro-6h-dibenso (b,d) pyraner och -pyranoner | |
NO774503L (no) | Fremgangsmaate for fremstilling av oktahydro-indolo(2,3,a)-chinoliziner | |
SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
NO153221C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner. | |
NO146607C (no) | Fremgangsmaate for fremstilling av gelatin. | |
SE7708824L (sv) | Forfarande for framstellning av 2,6-di-tert butylfenol | |
SE7512422L (sv) | Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
SE7608453L (sv) | Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
SE7507482L (sv) | Forfarande for framstellning av substituerade l-sulfonylbensimidazoler. | |
SE446726B (sv) | Forfarande for framstellning av 16-metoxiprostaglandiner |